Assoc Prof Dr. Edin Nevzati | Best Researcher Award | Best Researcher Award

Assoc Prof Dr. Edin Nevzati | Best Researcher Award | Best Researcher Award

Denver Health and Hospital Authority, United States

Profileย 

Google Scholarย 

๐Ÿง  Early Academic Pursuits

Dr. Edin Nevzati’s journey in the medical field began with an unwavering commitment to academic excellence. He pursued his medical education with a focus on neurosurgery, quickly distinguishing himself as a dedicated and talented student. Throughout his early academic years, Dr. Nevzati exhibited a strong passion for the complexities of the human brain and spinal cord, which led him to specialize in the field of neurosurgery. His early years were marked by rigorous training in Switzerland, where he gained invaluable experience in some of the most renowned clinics in Europe.

๐Ÿ‘จโ€โš•๏ธ Professional Endeavors

After completing his academic training, Dr. Nevzati embarked on a professional career that has spanned multiple countries and continents. He has worked in prestigious institutions in both Switzerland and the United States, bringing his expertise to the forefront of neurosurgical practice. Currently, he is a physician and neurosurgeon at Denver Health and Hospital Authority, where he continues to make significant contributions to the field. His clinical focus is on spinal and cranial oncology, and he is deeply involved in the surgical treatment of patients with complex neurosurgical conditions.

๐Ÿงฌ Contributions and Research Focus

Dr. Nevzati’s contributions to neurosurgery are not limited to his clinical work; he is also a prolific researcher with a focus on advancing surgical techniques and improving patient outcomes. His research spans various topics within neurosurgery, with a particular emphasis on spinal and cranial oncology. He is the founder of the Swiss Spinal Tumor Registry (Swiss-STR), a groundbreaking initiative that has brought together multiple international centers to study and improve treatment methods for spinal tumors. Dr. Nevzati’s research is characterized by its innovative approach, combining clinical practice with cutting-edge technology to optimize surgical outcomes.

๐Ÿ† Accolades and Recognition

Dr. Nevzati’s work has not gone unnoticed in the medical community. He has received numerous awards and recognitions for his contributions to neurosurgery and research. His leadership in establishing the Swiss Spinal Tumor Registry is particularly noteworthy, as it has become a vital resource for neurosurgeons worldwide. Additionally, his research has been published in several high-impact journals, reflecting the significance and quality of his work.

๐ŸŒ Impact and Influence

Dr. Nevzati’s influence extends beyond his immediate clinical and research environment. He has become a respected figure in the global neurosurgical community, contributing to the advancement of knowledge and the development of new surgical techniques. His work on the biomechanics of spinal stabilization and the development of biodegradable embolization materials has had a profound impact on the field, offering new hope for patients with challenging conditions.

๐ŸŒŸ Legacy and Future Contributions

As Dr. Nevzati continues his career, his legacy is already taking shape. His contributions to neurosurgery, particularly in the areas of spinal and cranial oncology, have set new standards for care and research. Looking forward, Dr. Nevzati is committed to furthering his research and continuing to innovate in the field of neurosurgery. His ongoing projects and collaborations promise to bring about even more significant advancements, ensuring that his impact will be felt for generations to come.

Publicationsย 

Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases

Authors: S. Marbacher, E. Klinger, L. Schwyzer, I. Fischer, E. Nevzati, M. Diepers, et al.

Journal: Neurosurgical Focus

Year: 2014

Estrogen induces nitric oxide production via nitric oxide synthase activation in endothelial cells

Authors: E. Nevzati, M. Shafighi, K.D. Bakhtian, H. Treiber, J. Fandino, A.R. Fathi

Journal: Neurovascular Events After Subarachnoid Hemorrhage: Towards Experimental and Clinical Standards

Year: 2015

Incidence and outcome of aneurysmal subarachnoid hemorrhage: the Swiss Study on Subarachnoid Hemorrhage (Swiss SOS)

Authors: B. Schatlo, C. Fung, M.N. Stienen, A.R. Fathi, J. Fandino, N.R. Smoll, et al.

Journal: Stroke

Year: 2021

Accuracy of pedicle screw placement in the thoracic and lumbosacral spine using a conventional intraoperative fluoroscopy-guided technique: a national neurosurgical education

Authors: E. Nevzati, S. Marbacher, J. Soleman, W.N. Perrig, M. Diepers, A. Khamis, et al.

Journal: World Neurosurgery

Year: 2014

Systematic review of in vivo animal models of subarachnoid hemorrhage: species, standard parameters, and outcomes

Authors: S. Marbacher, B. Grรผter, S. Schรถpf, D. Croci, E. Nevzati, D. Dโ€™Alonzo, et al.

Journal: Translational Stroke Research

Year: 2019

Prof Dr. Juan Li | Best Researcher Award | Best Researcher Award

Prof Dr. Juan Li-Best Researcher Award-Best Researcher Award

Prof Dr. Juan Li, Nanfang Hospital, Southern Medical University, Guangzhou, China

๐Ÿ”— Professional Profiles

๐Ÿ… Academic and Professional Background

Dr. Li Juan is a chief physician, doctoral/postdoctoral tutor, and the esteemed director of Rheumatology and Immunology at Nanfang Hospital, Southern Medical University. Recognized as an instructor for inheriting the academic experience of senior Chinese medicine experts, she is a renowned practitioner in Guangdong Province and one of the province’s first top ten medical leading talents.

๐Ÿ”ฌ Research and Innovations

Dr. Li Juan has led and completed twenty-two significant research projects, making substantial contributions to the fields of rheumatology and traditional Chinese medicine.

๐Ÿ“š Recent Publications

  1. Fusobacterium nucleatum and Rheumatoid Arthritis – Cell Host Microbe, 2023 (IF 30.3)
  2. Neutrophils Extracellular Traps in Rheumatoid Arthritis – RMD Open, 2024 (IF 6.2)
  3. DKK-1’s Role in Bone Destruction – Inflammation, 2023 (IF 5.1)
  4. Natural Killer Cells and Collagen-Induced Arthritis – Front Immunol, 2022 (IF 8.786)
  5. Resveratrol and Gouty Arthritis – J Inflamm Res, 2021 (IF 6.924)
  6. Paclitaxel’s Effect on Synoviocytes – Front Pharmacol, 2021 (IF 5.811)
  7. Monocytic MDSCs and Bone Erosion – Rheumatology (Oxford), 2021 (IF 7.583)
  8. Oridonin and Liver Injury – Oxid Med Cell Longev, 2021 (IF 6.543)
  9. IDO1 and Acute Liver Failure – Free Radic Biol Med, 2021 (IF 7.372)
  10. Machine Learning in Polymyositis and Dermatomyositis – Clin Exp Rheumatol, 2022 (IF 3.7)

๐Ÿš€ Patents

Dr. Li has one patent published/under process.

๐Ÿค Collaborations

She is actively involved in several high-profile collaborations, including the Overseas Cooperation Project of the National Natural Science Foundation of China and projects on traditional Chinese medicine at the national level.

๐ŸŒ Professional Memberships

Dr. Li holds several key positions in national and regional professional organizations, such as:

  • Chairman of the National Regional Diagnosis and Treatment Center for Rheumatology of Integrated Traditional Chinese and Western Medicine
  • Member of the Rheumatology Branch of the Chinese Medical Association
  • Vice Chairman of the Chinese Medicine Immunity Committee of the World Federation of Chinese Medical Societies

๐ŸŒฑ Areas of Research

  • Pathogenesis of rheumatoid arthritis and intervention mechanisms of Traditional Chinese Medicine
  • Basic and clinical research on gout
  • Research and development of anti-osteoporosis traditional Chinese medicine

๐ŸŽ–๏ธ Contributions

Dr. Li has presided over 8 national natural science funds and more than 20 other major projects. She has led and participated in over 30 clinical studies and published more than 30 SCI papers. Her groundbreaking work has earned her prestigious awards, including the first prize of science and technology from the China Association of Integrated Traditional Chinese and Western Medicine and the second prize of Guangdong Science and Technology Progress.

๐ŸŒ Dr. Li Juan’s dedication to integrating traditional Chinese medicine with modern rheumatology continues to advance the field, making significant strides in both scientific understanding and clinical practice.

Publication Top Noted

Internalisation of Neutrophils Extracellular Traps by Macrophages Aggravate Rheumatoid Arthritis via Rab5a

    • Authors: Ye, H., Yang, Q., Guo, H., …, Zheng, S., Li, J.
    • Journal: RMD Open
    • Year: 2024

DKK-1 and Its Influences on Bone Destruction: A Comparative Study in Collagen-Induced Arthritis Mice and Rheumatoid Arthritis Patients

    • Authors: Zhao, D., Wu, L., Hong, M., …, Zhu, J., Li, J.
    • Journal: Inflammation
    • Year: 2024

2023 International Consensus Guidance for the Use of Tripterygium Wilfordii Hook F in the Treatment of Active Rheumatoid Arthritis

    • Authors: Zhang, X., Xia, J., Jiang, Y., …, Zhao, Z., Lipsky, P.E.
    • Journal: Journal of Autoimmunity
    • Year: 2024

Real-World Study of Effectiveness and Safety of Tongluo Kaibi Tablet in Treatment of Arthritis (Rheumatoid Arthritis, Knee Osteoarthritis) | ้€š็ปœๅผ€็—น็‰‡ๆฒป็–—ๅ…ณ่Š‚็‚Ž๏ผˆ็ฑป้ฃŽๆนฟๅ…ณ่Š‚็‚Žใ€่†้ชจๅ…ณ่Š‚็‚Ž๏ผ‰็–—ๆ•ˆๅŠๅฎ‰ๅ…จๆ€ง็š„็œŸๅฎžไธ–็•Œ็ ”็ฉถ

    • Authors: He, X.-H., Shi, Y.-Y., Zhou, X.-L., …, Zhang, Z.-K., Huang, Q.-C.
    • Journal: Chinese Traditional and Herbal Drugs
    • Year: 2023

Fusobacterium Nucleatum Aggravates Rheumatoid Arthritis through FadA-Containing Outer Membrane Vesicles

    • Authors: Hong, M., Li, Z., Liu, H., …, Zhou, H., Li, J.
    • Journal: Cell Host and Microbe
    • Year: 2023